Back to List View Graph View

Epigallocatechin gallate

Epigallocatechin gallate (EGCG) is a major catechin polyphenol found in tea and is widely studied as a bioactive natural product with antioxidant, anti-inflammatory, and putative anticancer properties.

Where the papers sit

25 papers from the last 6 months study epigallocatechin gallate directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 24 preclinical · 1 unclassified

Themes one subject · 1 new direction

Those 25 are all about one subject.

  • EGCG Therapeutic Applications

    EGCG research is moving toward targeted delivery and combination treatment across cancer, inflammatory disease, infection, tissue injury, and metabolic disorders. Nanoparticles, hydrogels, liposomes, microneedles, and colon- or kidney-directed systems recur as strategies to improve stability and tissue exposure. NF-κB suppression, ROS control, immune remodeling, angiogenesis inhibition, and reversal of treatment resistance are recurring biological themes. Evidence remains preclinical and broad, without a single dominant disease or mechanism.

    25 papers

NEW DIRECTION

EGCG is presented as a trigger of BAT-independent thermogenesis in obesity

The obesity model in high-fat-diet-induced obese mice treated with EGCG assumed the compound could counter obesity through its established anti-obesity and immunometabolic effects, but instead reported a BAT-independent thermogenic switch alongside remodeling of the immune microenvironment in subcutaneous adipose tissue. This gives EGCG a role as a direct inducer of energy expenditure that does not depend on brown adipose tissue activity, extending its use beyond the anticancer, anti-inflammatory, antioxidant, antimicrobial, and delivery-system roles represented elsewhere in the set 42607554Aug.

epigallocatechin gallate chemical structure

Papers

The 25 papers from the last 6 months that study epigallocatechin gallate directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

EGCG Therapeutic Applications (25)
  1. Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. European journal of pharmacology · 12 Nov 2026 PMID 43020306
  2. Shape-memory scaffold targets inflammation and fibrosis to restore endometrium and fertility in intrauterine adhesions. Science advances · 6 Nov 2026 PMID 42993828
  3. Spatiotemporal bilayer microneedle patches enable bacterial control and ROS-driven immunomodulation for infected wound healing. Journal of materials chemistry. B · 19 Oct 2026 PMID 42895083
  4. Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-κB signaling and disrupting mitochondrial homeostasis. Bioorganic chemistry · 8 Oct 2026 PMID 42849137
  5. Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice. Journal of the Egyptian National Cancer Institute · 17 Sept 2026 PMID 42752748
  6. Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of controlled release : official journal of the Controlled Release Society · 16 Sept 2026 PMID 42749134
  7. An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
  8. Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
  9. Albumin-Coated Mesoporous Polydopamine Nanoparticles for Renal Delivery of Epigallocatechin Gallate against Cisplatin-Induced Acute Kidney Injury. ACS applied materials & interfaces · 2 Sept 2026 PMID 42686388
  10. EGCG combats obesity by triggering a BAT-independent thermogenic switch and remodeling the immune microenvironment in subcutaneous adipose tissue. Phytomedicine : international journal of phytotherapy and phytopharmacology · 17 Aug 2026 PMID 42607554
  11. QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
  12. Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer. Oncogene · 23 Jul 2026 PMID 42493544
  13. Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
  14. Solid nano-lipoidal intelligent premix (SNIP): designing, optimization, and characterization. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 22 Jul 2026 PMID 42484807
  15. Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
  16. Epigallocatechin gallate enhances panobinostat-induced cytotoxicity through HDAC modulation in colorectal cancer cells. Molecular biology reports · 15 Jul 2026 PMID 42455377
  17. Multicomponent Micelles with Boosted Stability of Iminoboronates. Biomacromolecules · 3 Jul 2026 PMID 42397949
  18. Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
  19. Polyphenol-based nanoparticles enhancing doxycycline efficacy for acne therapy. Journal of materials chemistry. B · 26 Jun 2026 PMID 42358218
  20. Kinetics of Lignin/Epigallocatechin Gallate Co-Release by Multiscale Structures of Dual-Dynamic Cross-Linked Hydrogels. Biomacromolecules · 19 Jun 2026 PMID 42319084
  21. Multi-mode ultrasonic-driven self-assembly of banana-derived resistant starch nanoparticles for epigallocatechin gallate encapsulation and in vitro antiglycation evaluation. International journal of biological macromolecules · 16 Jun 2026 PMID 42303019
  22. Self-assembled nanoparticles of epigallocatechin gallate and tannic acid against triple-negative breast cancer via mediating mitochondrial damage. Nanotechnology · 9 Jun 2026 PMID 42263713
  23. Structure-function analysis of sodium caseinate-gum arabic-EGCG ternary complexes prepared via ultrasound-assisted glycation. International journal of biological macromolecules · 4 Jun 2026 PMID 42242649
  24. Peanut protein-fortified alginate hydrogel beads for EGCG encapsulation: Fabrication, characterization, and in vitro digestive behavior. International journal of biological macromolecules · 3 Jun 2026 PMID 42235770
  25. Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173

By study type

Preclinical: animal, cell and lab studies (24)
  1. Shape-memory scaffold targets inflammation and fibrosis to restore endometrium and fertility in intrauterine adhesions. Science advances · 6 Nov 2026 PMID 42993828
  2. Spatiotemporal bilayer microneedle patches enable bacterial control and ROS-driven immunomodulation for infected wound healing. Journal of materials chemistry. B · 19 Oct 2026 PMID 42895083
  3. Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-κB signaling and disrupting mitochondrial homeostasis. Bioorganic chemistry · 8 Oct 2026 PMID 42849137
  4. Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice. Journal of the Egyptian National Cancer Institute · 17 Sept 2026 PMID 42752748
  5. Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of controlled release : official journal of the Controlled Release Society · 16 Sept 2026 PMID 42749134
  6. An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
  7. Harnessing (-)-epigallocatechin-3-gallate (EGCG) with chitosan-coated liposomes to modulate the radiation effect in cancer cells through alteration in the miR-139-5p-β-catenin axis. Biomaterials science · 15 Sept 2026 PMID 42741861
  8. Albumin-Coated Mesoporous Polydopamine Nanoparticles for Renal Delivery of Epigallocatechin Gallate against Cisplatin-Induced Acute Kidney Injury. ACS applied materials & interfaces · 2 Sept 2026 PMID 42686388
  9. EGCG combats obesity by triggering a BAT-independent thermogenic switch and remodeling the immune microenvironment in subcutaneous adipose tissue. Phytomedicine : international journal of phytotherapy and phytopharmacology · 17 Aug 2026 PMID 42607554
  10. QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
  11. Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer. Oncogene · 23 Jul 2026 PMID 42493544
  12. Multi-modular responsive hydroxypropyl chitosan-based hydrogel microspheres for stage-specific therapy in infected wounds. Carbohydrate polymers · 23 Jul 2026 PMID 42493128
  13. Solid nano-lipoidal intelligent premix (SNIP): designing, optimization, and characterization. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 22 Jul 2026 PMID 42484807
  14. Nanoparticle-Cross-Linked Smart Responsive Hydrogels for Antimicrobial, Anti-Inflammatory, and Antioxidant Treatment of Diabetic Wounds. Biomacromolecules · 21 Jul 2026 PMID 42479468
  15. Epigallocatechin gallate enhances panobinostat-induced cytotoxicity through HDAC modulation in colorectal cancer cells. Molecular biology reports · 15 Jul 2026 PMID 42455377
  16. Multicomponent Micelles with Boosted Stability of Iminoboronates. Biomacromolecules · 3 Jul 2026 PMID 42397949
  17. Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
  18. Polyphenol-based nanoparticles enhancing doxycycline efficacy for acne therapy. Journal of materials chemistry. B · 26 Jun 2026 PMID 42358218
  19. Kinetics of Lignin/Epigallocatechin Gallate Co-Release by Multiscale Structures of Dual-Dynamic Cross-Linked Hydrogels. Biomacromolecules · 19 Jun 2026 PMID 42319084
  20. Multi-mode ultrasonic-driven self-assembly of banana-derived resistant starch nanoparticles for epigallocatechin gallate encapsulation and in vitro antiglycation evaluation. International journal of biological macromolecules · 16 Jun 2026 PMID 42303019
  21. Self-assembled nanoparticles of epigallocatechin gallate and tannic acid against triple-negative breast cancer via mediating mitochondrial damage. Nanotechnology · 9 Jun 2026 PMID 42263713
  22. Structure-function analysis of sodium caseinate-gum arabic-EGCG ternary complexes prepared via ultrasound-assisted glycation. International journal of biological macromolecules · 4 Jun 2026 PMID 42242649
  23. Peanut protein-fortified alginate hydrogel beads for EGCG encapsulation: Fabrication, characterization, and in vitro digestive behavior. International journal of biological macromolecules · 3 Jun 2026 PMID 42235770
  24. Evaluation of antioxidant-enriched cream formulations and their clinical effects in mild to moderate atopic dermatitis. International journal of pharmaceutics · 1 Jun 2026 PMID 42225173
Unclassified: not yet indexed with MeSH (1)
  1. Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. European journal of pharmacology · 12 Nov 2026 PMID 43020306